1,982
Views
9
CrossRef citations to date
0
Altmetric
Research Papers

Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity

ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon & ORCID Icon show all
Pages 1043-1052 | Received 22 Feb 2022, Accepted 18 Mar 2022, Published online: 19 Apr 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Zainab M. Elsayed, Hadia Almahli, Alessio Nocentini, Andrea Ammara, Claudiu T. Supuran, Wagdy M. Eldehna & Sahar M. Abou-Seri. (2023) Development of novel anilinoquinazoline-based carboxylic acids as non-classical carbonic anhydrase IX and XII inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Shaik Mahammad Ghouse, Kavyaraj Bahatam, Andrea Angeli, Gaurav Pawar, Krishna Kartheek Chinchilli, Venkata Madhavi Yaddanapudi, Arifuddin Mohammed, Claudiu T. Supuran & Srinivas Nanduri. (2023) Synthesis and biological evaluation of new 3-substituted coumarin derivatives as selective inhibitors of human carbonic anhydrase IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Jekaterīna Ivanova, Morteza Abdoli, Alessio Nocentini, Raivis Žalubovskis & Claudiu T. Supuran. (2023) Derivatives of 4-methyl-1,2,3-benzoxathiazine 2,2-dioxide as selective inhibitors of human carbonic anhydrases IX and XII over the cytosolic isoforms I and II. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Jekaterina Ivanova, Morteza Abdoli, Alessio Nocentini, Raivis Žalubovskis & Claudiu T. Supuran. (2023) 1,2,3-Benzoxathiazine-2,2-dioxides – effective inhibitors of human carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1, pages 225-238.
Read now
H.E. Bostancı, U.A. Çevik, R. Kapavarapu, Y.C. Güldiken, Z.D.Ş. Inan, Ö.Ö. Güler, T.K. Uysal, A. Uytun, F.N. Çetin, Y. Özkay & Z.A. Kaplancıklı. (2023) Synthesis, biological evaluation and in silico studies of novel thiadiazole-hydrazone derivatives for carbonic anhydrase inhibitory and anticancer activities. SAR and QSAR in Environmental Research 34:7, pages 543-567.
Read now
Tarfah Al-Warhi, Mostafa M. Elbadawi, Alessandro Bonardi, Alessio Nocentini, Ahmed A. Al-Karmalawy, Nada Aljaeed, Ohoud J. Alotaibi, Hatem A. Abdel-Aziz, Claudiu T. Supuran & Wagdy M. Eldehna. (2022) Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 2635-2643.
Read now

Articles from other publishers (3)

Metin Yildirim, Samet Poyraz & Mehmet Ersatir. (2023) Recent advances on biologically active coumarin-based hybrid compounds. Medicinal Chemistry Research 32:4, pages 617-642.
Crossref
Monalisa Mahapatra, Suman K. Mekap, Suvadeep Mal, Jyotirmaya Sahoo, Sanjeeb K. Sahoo & Sudhir K. Paidesetty. (2023) Coumaryl‐sulfonamide moiety: Unraveling their synthetic strategy and specificity toward  h CA IX/XII, facilitating anticancer drug development . Archiv der Pharmazie 356:4.
Crossref
Rinshana Fathima Abdul Azeez, Susi Zara, Alessia Ricci, Sanal Dev, Ajeesh Vengamthodi, Fathima Sahla Kavully, Raihan Arikkattel Abdu, Kadeeja Thottungal Kalathil, Mohamed A. Abdelgawad, Bijo Mathew & Simone Carradori. (2022) Integrating N-alkyl amide in the chalcone framework: synthesis and evaluation of its anti-proliferative potential against AGS cancer cell line. Research on Chemical Intermediates 49:1, pages 203-220.
Crossref